Edrophonium chloride is a short-acting acetylcholinesterase inhibitor belonging to the pyridinium class, primarily used as a diagnostic agent for myasthenia gravis and as an antidote for curare poisoning.… Read more
Edrophonium chloride is a short-acting acetylcholinesterase inhibitor belonging to the pyridinium class, primarily used as a diagnostic agent for myasthenia gravis and as an antidote for curare poisoning. By increasing acetylcholine levels at the neuromuscular junction, it serves a critical clinical function in reversing muscle weakness. To ensure the integrity and precision of pharmaceutical analysis, laboratories rely on high-quality reference standards of the active ingredient, along with its related pharmacopeial and non-pharmacopeial impurities. Additionally, stable isotope labelled compounds such as Edrophonium-d5 chloride are essential tools for mass spectrometry applications, serving as internal standards to improve accuracy during impurity profiling and method validation. These research materials facilitate rigorous quality control processes, enabling accurate identification and quantification of the drug and its related substances within various analytical frameworks.